Get the Stockscreener App
25.42
4.33%
-1.15
After Hours:
25.50
0.08
+0.31%
Progyny Inc stock is traded at $25.42, with a volume of 1.44M.
It is down -4.33% in the last 24 hours and down -17.06% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$26.57
Open:
$26.27
24h Volume:
1.44M
Relative Volume:
1.01
Market Cap:
$1.95B
Revenue:
$1.29B
Net Income/Loss:
$67.69M
P/E Ratio:
33.01
EPS:
0.7701
Net Cash Flow:
$184.42M
1W Performance:
-18.97%
1M Performance:
-17.06%
6M Performance:
+21.16%
1Y Performance:
+16.71%
1-Day Range:
$25.39
$26.31
1-Week Range:
$25.09
$31.43
52-Week Range:
$16.10
$33.06
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
25.42 | 2.04B | 1.29B | 67.69M | 184.42M | 0.7701 |
UNH
Unitedhealth Group Inc
|
405.59 | 361.00B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
94.72 | 119.58B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
399.14 | 84.66B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
277.41 | 72.37B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
388.83 | 44.77B | 137.20B | 1.15B | 1.27B | 9.3439 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-20-26 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Jan-08-26 | Upgrade | Truist | Hold → Buy |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-12-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-13-24 | Downgrade | Truist | Buy → Hold |
| Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
| May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Sep-27-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Initiated | BTIG Research | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-07-22 | Initiated | Truist | Buy |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
| Sep-30-21 | Initiated | Berenberg | Buy |
| Aug-12-21 | Initiated | Barclays | Overweight |
| Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-02-20 | Initiated | Guggenheim | Buy |
| Nov-19-19 | Initiated | Citigroup | Buy |
| Nov-19-19 | Initiated | Goldman | Buy |
| Nov-19-19 | Initiated | JP Morgan | Overweight |
| Nov-19-19 | Initiated | Piper Jaffray | Overweight |
| Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
PGNY Maintains Rating by Barclays -- Price Target Lowered to $30 - GuruFocus
Sei Investments Co. Decreases Stake in Progyny, Inc. $PGNY - marketbeat.com
Progyny Inc (PGNY) Stock Down 4.6% -- Now Undervalued? GF Score: 93/100 - GuruFocus
Progyny Drops 5.4% Amid Sector-Wide Selling - AlphaStreet
Progyny, Inc. $PGNY Shares Sold by Janus Henderson Group PLC - marketbeat.com
Why Progyny (PGNY) Shares Are Sliding Today - Yahoo Finance UK
Progyny (PGNY) Stock May Still Trade At A Discount As Earnings Hold Up - Yahoo Finance
Quantinno Capital Management LP Grows Position in Progyny, Inc. $PGNY - MarketBeat
PGNY Q2 CY2026 Deep Dive: Seasonality and Guidance Weigh on Positive Underlying Performance - Yahoo Finance
A Quick Look at Today's Ratings for Progyny(PGNY.US), With a Forecast Between $31 to $35 - Moomoo
PGNY SWOT Analysis: Strong Growth Potential Revealed in 10-Q Fil - GuruFocus
Progyny Inc (PGNY) Stock News Today - TradingKey
Progyny Posts Record Q2 Results, Expands Client Base - The Globe and Mail
CCORF Maintains Progyny(PGNY.US) With Buy Rating, Cuts Target Price to $35 - Moomoo
Progyny, Inc. Releases Q2 2026 Form 10-Q Filing Highlighting Financials and Risks - Kalkine Media
Why Progyny Stock Plunged, Then Gradually Recovered Today - AOL.com
Progyny CEO to present at Canaccord Genuity Ann... - Pluang
Progyny (NASDAQ:PGNY) Shares Gap DownHere's What Happened - marketbeat.com
Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference - GlobeNewswire
Progyny CEO’s Aug. 11 Boston session will have a live audiocast - Stock Titan
Progyny, Inc. 2026: Revenue $350.51M, EPS $0.34— 10-Q Summary - TradingView
Progyny, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Progyny, Inc. Stock 12‑Month Price Target Cut to $33.82, Implies 12% Upside - TradingView
Progyny Q2 2026 Earnings Call Transcript - marketbeat.com
Progyny, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PGNY) 2026-08-07 - Seeking Alpha
Progyny Outlook FY Adjusted Ebitda USD 233-24 - Moomoo
Progyny Inc (PGNY) (Q2 2026) Earnings Call Highlights: Record Re - GuruFocus
106,654 Shares in Progyny, Inc. $PGNY Bought by Empowered Funds LLC - marketbeat.com
Is Progyny Inc (PGNY) Fairly Valued After Q2 Earnings? EPS Matches Estimate at $0.34 with Revenue of $350.5 Million - GuruFocus
Progyny Q2 Earnings Call Highlights - marketbeat.com
Progyny Q2 2026 earnings: Margin expansion lifts profit faster than revenue - TradingKey
Progyny (PGNY) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Progyny (NASDAQ:PGNY) Issues FY 2026 Earnings Guidance - marketbeat.com
Progyny (NASDAQ:PGNY) Issues Q3 2026 Earnings Guidance - marketbeat.com
Earnings call transcript: Progyny beats Q2 2026 estimates, shares sink after hours - Investing.com
Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
Progyny, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
PROGYNY ($PGNY) Releases Q2 2026 Earnings - Quiver Quantitative
Q2 2026 Progyny Inc Earnings Call Transcript - GuruFocus
Progyny: Q2 Earnings Snapshot - Barchart.com
Progyny Q2 revenue rises 5%, slightly beats estimates - TradingView
Progyny’s (NASDAQ:PGNY) Q2 CY2026: Beats On Revenue But Stock Drops 10.2% - Yahoo Finance
Progyny, Inc. Announces Second Quarter 2026 Results - The Manila Times
Progyny: Member Engagement Typically Lessens During the Peak of the Summer Mos >PGNY - Moomoo
Tranche Update on Progyny, Inc.'s Equity Buyback Plan announced on May 26, 2026. - marketscreener.com
Earnings Flash (PGNY) Progyny, Inc. Reports Q2 Revenue $350.5M, vs. FactSet Est of $348.6M - marketscreener.com
(PGNY) Progyny, Inc. Expects Q3 Revenue Range $335.0M$345.0M - marketscreener.com
(PGNY) Progyny, Inc. Expects Q3 Adjusted EPS Range $0.50$0.52 - marketscreener.com
PROGYNY Q2 NET INCOME USD 28.052 MILLION - Moomoo
Progyny, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Progyny earnings in focus as utilization trends face scrutiny By Investing.com - Investing.com Nigeria
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):